| 35863630 | Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis. | Clin Microbiol Infect | 2023 |
| 37923823 | HLA allele-calling using multi-ancestry whole-exome sequencing from the UK Biobank identifies 129 novel associations in 11 autoimmune diseases. | Commun Biol | 2023 |
| 37425840 | Targeting hepatitis B vaccine escape using immunogenetics in Bangladeshi infants. | medRxiv | 2023 |
| 37368847 | Dose-dependent Association of Alcohol Consumption With Obesity and Type 2 Diabetes: Mendelian Randomization Analyses. | J Clin Endocrinol Metab | 2023 |
| 37069249 | Circulating proteins to predict COVID-19 severity. | Sci Rep | 2023 |
| 36805566 | Proteome-wide Mendelian randomization implicates nephronectin as an actionable mediator of the effect of obesity on COVID-19 severity. | Nat Metab | 2023 |
| 36773317 | Increasing serum iron levels and their role in the risk of infectious diseases: a Mendelian randomization approach. | Int J Epidemiol | 2023 |
| 36635386 | Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases. | Nat Genet | 2023 |
| 36528344 | Mendelian randomisation and vitamin D: the importance of model assumptions. | Lancet Diabetes Endocrinol | 2023 |
| 34464734 | Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. | Clin Microbiol Infect | 2022 |
| 35708486 | Novel genes and sex differences in COVID-19 severity. | Hum Mol Genet | 2022 |
| 35728748 | Staphylococcus aureus bacteremia mortality across country income groups: A secondary analysis of a systematic review. | Int J Infect Dis | 2022 |
| 35598856 | Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis. | Clin Microbiol Infect | 2022 |
| 35415199 | What Is the Optimal Follow-up Length for Mortality in <i>Staphylococcus aureus</i> Bacteremia? Observations From a Systematic Review of Attributable Mortality. | Open Forum Infect Dis | 2022 |
| 36271419 | Dehydration is associated with production of organic osmolytes and predicts physical long-term symptoms after COVID-19: a multicenter cohort study. | Crit Care | 2022 |
| 35992131 | Causal associations between body fat accumulation and COVID-19 severity: A Mendelian randomization study. | Front Endocrinol (Lausanne) | 2022 |
| 35863836 | Low-dose trimethoprim-sulfamethoxazole for the treatment of <i>Pneumocystis jirovecii</i> pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial. | BMJ Open | 2022 |
| 36327219 | Exome-wide association study to identify rare variants influencing COVID-19 outcomes: Results from the Host Genetics Initiative. | PLoS Genet | 2022 |
| 36376796 | Correction: The dynamic changes and sex differences of 147 immune-related proteins during acute COVID-19 in 580 individuals. | Clin Proteomics | 2022 |
| 34889978 | Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity. | Hum Genet | 2022 |
| 35243486 | How Generalizable Are Randomized Controlled Trials (RCTs) in Staphylococcus aureus Bacteremia? A Description of the Mortality Gap Between RCTs and Observational Studies. | Clin Infect Dis | 2022 |
| 35027740 | Multi-ancestry fine mapping implicates OAS1 splicing in risk of severe COVID-19. | Nat Genet | 2022 |
| 35339678 | Staphylococcus aureus bacteraemia mortality: a systematic review and meta-analysis. | Clin Microbiol Infect | 2022 |
| 32667982 | Adjunctive Daptomycin in the Treatment of Methicillin-susceptible Staphylococcus aureus Bacteremia: A Randomized, Controlled Trial. | Clin Infect Dis | 2021 |
| 33655273 | A catalog of associations between rare coding variants and COVID-19 outcomes. | medRxiv | 2021 |
| 33791713 | Alternative splicing of OAS1 alters the risk for severe COVID-19. | medRxiv | 2021 |
| 33540128 | Remdesivir and systemic corticosteroids for the treatment of COVID-19: A Bayesian re-analysis. | Int J Infect Dis | 2021 |
| 33758887 | Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. | medRxiv | 2021 |
| 33813124 | Handheld infrared thermometer to evaluate cellulitis: the HI-TEC study. | Clin Microbiol Infect | 2021 |
| 33894072 | Comparative effectiveness of amphotericin B, azoles and echinocandins in the treatment of candidemia and invasive candidiasis: A systematic review and network meta-analysis. | Mycoses | 2021 |
| 33633408 | A Neanderthal OAS1 isoform protects individuals of European ancestry against COVID-19 susceptibility and severity. | Nat Med | 2021 |
| 34988242 | On the Treatment of <i>Pneumocystis jirovecii</i> Pneumonia: Current Practice Based on Outdated Evidence. | Open Forum Infect Dis | 2021 |
| 34717823 | WITHDRAWN: Targeting of vitamin D supplementation to individuals with deficiency. | Lancet Diabetes Endocrinol | 2021 |
| 34597274 | Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality. | J Clin Invest | 2021 |
| 34826237 | Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality. | Sci Adv | 2021 |
| 34043590 | Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19. | J Clin Invest | 2021 |
| 34156980 | Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply. | J Clin Invest | 2021 |
| 34061844 | Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study. | PLoS Med | 2021 |
| 34115965 | Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. | Am J Hum Genet | 2021 |
| 33449069 | Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis. | JAMA Intern Med | 2021 |
| 33349849 | The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study. | Int J Epidemiol | 2021 |
| 33007475 | Tocilizumab versus the Covid19 tempest: All's well that ends well or much ado about nothing? | Clin Microbiol Infect | 2021 |
| 32845981 | Reply to Volpicelli et al. | Clin Infect Dis | 2021 |
| 32479781 | Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. | Clin Microbiol Infect | 2020 |
| 31973783 | Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremia. | Infect Control Hosp Epidemiol | 2020 |
| 33398295 | Failure to replicate the association of rare loss-of-function variants in type I IFN immunity genes with severe COVID-19. | medRxiv | 2020 |
| 33209948 | Clinical Trials Increase Off-Study Drug Use: A Segmented Time-Series Analysis. | Open Forum Infect Dis | 2020 |
| 33005699 | Real-world Time to Positivity of 2 Widely Used Commercial Blood Culture Systems in Patients With Severe Manifestations of Sepsis: An Analysis of the FABLED Study. | Open Forum Infect Dis | 2020 |
| 32592749 | Elevated body mass index is associated with an increased risk of infectious disease admissions and mortality: a mendelian randomization study. | Clin Microbiol Infect | 2020 |
| 32391402 | Low-Dose TMP-SMX in the Treatment of <i>Pneumocystis jirovecii</i> Pneumonia: A Systematic Review and Meta-analysis. | Open Forum Infect Dis | 2020 |